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ABSTRACT  
Objective: The authors performed meta-analyses of randomized controlled trials to examine the effects of cognitive 
training on ADHD symptoms, neuropsychological deficits and academic skills in children/adolescents with ADHD. 
Method: The authors searched Pubmed, Ovid, Web of Science, ERIC and CINAHAL databases through May 18 th, 
2014. Data were aggregated using random-effects models. Studies were evaluated with the Cochrane risk of bias tool. 
Results: Sixteen of 695 non-duplicate records were analyzed (759 ADHD children). When all types of training were 
considered together, there were significant effects on total ADHD (Standardized Mean Difference [SMD]=0.37, 95% 
CI=0.09-0.66) and inattentive symptoms (SMD=0.47, 95% CI=0.14-0.80) for reports by raters most proximal to the 
treatment setting (i.e., typically unblinded). These figures fell substantially when the outcomes were provided by 
probably blinded raters (ADHD total: SMD=0.20, 95% CI=0.01-0.40; inattention: SMD=0.32, 95% CI= - 0.01-0.66). 
Effects on hyperactivity/impulsivity symptoms were not significant. There were significant effects on laboratory tests of 
working memory (verbal: SMD=0.52, 95% CI=0.24-0.80; visual: SMD=0.47, 95% CI=0.23-0.70) and parent ratings of 
executive function (SMD=0.35, 95% CI=0.08-0.61). Effects on academic performance were not statistically significant. 
There were no effects of working memory training, specifically, on ADHD symptoms. Interventions targeting multiple 
neuropsychological deficits had large effects on ADHD symptoms rated by most proximal assessors (SMD=0.79, 95% 
CI=0.46-1.12). Conclusions: Despite improving working memory performance, cognitive training had limited effects 
on ADHD symptoms according to assessments based on blinded measures. Approaches targeting multiple 
neuropsychological processes may optimise the transfer of effects from cognitive deficits to clinical symptoms. 
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Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is a childhood-onset condition characterized by pervasive 
patterns of inattention and/or impulsivity-hyperactivity, which often persist into later life.1 Combinations of 
pharmacological and psychological approaches are recommended for its treatment.2 While medication is efficacious in 
randomized controlled trials (RCT) in the short/medium-term and is indicated as the first-line treatment (at least for 
severe cases2), it has a number of potential limitations – each affecting some patients. These include: (i) partial or non-
response;3 (ii) possible adverse effects;4 (iii) uncertainty about long term costs and benefits;5 (iv) poor adherence;6 and 
(v) negative medication-related attitudes from patients, parents or clinicians.7 Psychological treatments such as 
behavioral parent training are also widely used. However, a recent meta-analysis8 found no effects on ADHD symptoms 
when only ratings by assessors blind to treatment allocation were considered. 
In recent years, cognitive training has been investigated as a potential ADHD treatment.9 Building on evidence 
of brain plasticity from rehabilitation science and contemporary developmental neuroscience, cognitive training is 
premised on the notion that key brain networks implicated in ADHD can be strengthened, and the cognitive processes 
they subserve improved, through controlled exposures to information processing tasks.10 Thus, it is argued that 
cognitive training can reduce ADHD symptoms and improve functioning by targeting neuropsychological deficits 
thought to mediate ADHD pathophysiology. In keeping with the complex nature of ADHD neuropsychology,11 
cognitive training approaches have targeted a range of deficits (e.g., attentional control, working memory, inhibitory 
control). Currently, such training is typically delivered via computers using adaptive procedures - whereby training task 
difficulty is automatically increased across sessions to continually challenge the patient at the boundaries of their 
competence. This has been shown in neuroimaging studies to be necessary for sustaining neuronal changes.12, 13 
The efficacy of cognitive training for ADHD was addressed in a meta-analysis of non-pharmacological 
treatments for ADHD by Sonuga-Barke et al.,14 on behalf of the European ADHD Guidelines Group (EAGG). This 
meta-analysis focused solely on RCTs. Importantly, it addressed the issue of blinding by comparing outcomes rated by 
individuals most proximal to the therapeutic setting (often unblinded and invested in the patient and/or intervention) and 
those provided by reporters judged to be probably blinded. Effects of cognitive training on ADHD symptoms calculated 
using unblinded ratings were highly significant (SMD=0.64, 95% CI=0.33-0.95). These effects dropped substantially 
(SMD=0.24) and became statistically non-significant (95% CI= -0.24-0.72) when probably blinded measures were 
used. However, these results should be considered preliminary as only six RCTs were included. The authors concluded 
that more evidence was required, especially from trials where assessments were effectively blinded, before cognitive 
training could be supported as an ADHD treatment. A second meta-analysis by Rapport et al.,9 published more recently 
and exploring a wider range of outcomes, found similar effects. However, compared to Sonuga-Barke et al.,14 this more 
 5 
recent meta-analysis included only two additional peer-reviewed RCTs with outcomes related to ADHD core 
symptoms. Moreover, to increase statistical power, Rapport et al.9 included also non-RCTs and pooled across design 
types, making effect size estimates of the effects of cognitive training on ADHD core symptoms and related 
neuropsychological impairment difficult to interpret.   
A significant number of new RCTs of cognitive training for ADHD, not available for inclusion in these 
previous two meta-analyses,9, 14 have been published in the past two years, reflecting the current interest in cognitive 
training in this field. The greater number of trials now available allows a much more definitive estimate of the effects of 
cognitive training to be made. In the present paper we update the first EAGG cognitive training meta-analysis to include 
these new trials and extend its focus to cover effects on neuropsychological processes and academic functioning, which 
were not addressed in the previous EAGG meta-analysis.14 The focus on neuropsychological processes is important for 
two reasons. First, neuropsychological deficits are postulated to mediate the pathways between originating causes and 
disorder onset: improvements in neuropsychological functioning may therefore be a prerequisite for ADHD symptom 
reduction.15 Second, they are associated with functional impairments in their own right, independent of their association 
with ADHD symptomatology, especially in social and academic contexts.16 A broad range of training approaches have 
been used with ADHD populations. In the meta-analysis by Sonuga-Barke et al.,14 given the small number of studies 
available, trials with different techniques had to be pooled to generate an effect size estimate. However, given the 
increased number of trials now available, our aim was to explore training type specific effects through the use of sub-
analyses where sufficient numbers of trials existed.   
 
Methods  
The EAGG protocol for non-pharmacological interventions for ADHD was registered on the International 
Prospective Register of Systematic Reviews PROSPERO (http://www.crd.york.ac.uk/PROSPERO, protocol number: 
CRD42011001393). The same protocol was followed here. 
Inclusion and Exclusion Criteria 
  Only RCTs including interventions aimed to directly train a cognitive function were retained. As reported by 
the Cochrane group,17 in order to ensure high levels of methodological adequacy and to avoid the inevitable bias caused 
by dependence on investigators agreeing to provide data from unpublished studies, only published studies were 
included. Trials were included if participants had an ADHD diagnosis (any subtype) or met accepted cut-offs on 
validated ADHD rating scales and were between 3 and 18 years of age. Trials just involving children with ADHD 
comorbid with rare disorders (e.g., fragile X syndrome) were excluded. Control conditions allowed were “treatment as 
usual”, “wait list”, “active/placebo/sham” (i.e., involving other forms of computer-based activity or alternative training 
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regime). Trials were not excluded if patients received medication as part of normal treatment. In an extension of the 
EAGG protocol,14 trials could be included in this updated meta-analysis despite not reporting an ADHD outcome, if 
they reported neuropsychological and/or academic outcomes.  
Search Strategy 
Sonuga-Barke et al.14 included studies up to April 3rd, 2012. Here, using the same search strategy, our final 
search date was May 18th, 2014. Supplement 1 reports details about the search strategy and syntax for each database. 
Parallel searches were conducted separately by the first two authors. 
Outcome Measures 
For consistency with previous EAGG meta-analyses8 and in order to provide a robust estimate of effects, 
outcome domains were only analyzed if five or more RCTs were available. The outcomes analyzed were: ADHD 
symptoms (total ADHD as well as inattention and hyperactivity/impulsivity symptoms), parent ratings of executive 
functioning (e.g., Behavior Rating Inventory of Executive Function, BRIEF), standardized measures of reading and 
arithmetic ability, and laboratory-based measures of verbal and visual working memory, inhibition and attention. For 
neuropsychological outcomes, only scores from tasks different from those used for training were included in the 
analysis. 
Study Selection 
Articles’ titles and abstracts were screened independently by the first two authors. Final inclusion was based on 
the full text. Trials were blindly double-coded for eligibility by the first two authors. Disagreement was resolved by the 
senior author for three trials.  
Risk of bias assessment 
Two authors independently assessed trial risk of bias using five domains of the Cochrane Collaboration’s 
tool17: selection bias, performance bias, detection bias, attrition bias, and other bias. If there was disagreement between 
the two raters, the final rating was established through consensus with the involvement of the senior author. This 
occurred for four trials. 
Data Extraction and Statistical Analysis 
Trial information was entered into RevMan 5.0.18 Data extraction was independently performed and cross-
checked by the first two authors. Standardized mean difference (SMD) was calculated as mean pre- to post-treatment 
change in the intervention group minus the mean pre- to post-treatment change in the control group divided by the 
pooled pre-test standard deviation with a bias adjustment.19 SMDs for each trial were combined using the inverse-
variance method. Given the inherent heterogeneity of studies, random-effects models were used. The I2 statistic was 
calculated, a posteriori, to estimate between-trial SMD heterogeneity. For the most proximal analysis, parent ratings, if 
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available, were used for home-based, and teacher ratings for school-based interventions - except where it could be 
inferred from the manuscript’s text that teachers were less blinded than parents for home-based and parents less blinded 
than teachers for school based interventions (two trials20, 21). Probably blinded assessments were those made by an 
individual judged likely to be unaware of treatment allocation. In trials in which more than one such measure was 
available, the best-blinded measure was chosen. For home delivered interventions, teachers’ ratings were usually judged 
to be blinded while, for school based interventions, parents were judged to be blinded except where this could be 
inferred not to be the case from the text20, 21 or from e-mail exchange with the authors. As per protocol, where direct 
observations were available, we selected this over rating scale scores. This decision was based on the judgement that 
direct observations are likely to be -in general- better blinded than parent- or teacher-rated outcomes, even where the 
latter are made in a setting other than the therapeutic setting. Where multiple measures were available for a single 
outcome (as was sometimes the case for laboratory tasks), the one most frequently reported across included trials and/or 
which was judged to tap the core of the construct was selected. Sensitivity analyses were conducted including only 
trials: i) with active/sham control; ii) using working memory training; iii) using training targeting more than one 
neuropsychological domain (termed here “multiple process training”); and iv) with no/low medication (less than 30% of 
participants receiving medications). We also performed an additional sensitivity analysis excluding the study by Gray et 
al.22, in which all subjects had a diagnosis of ADHD plus coexisting intellectual disability. Publication bias was 
assessed with funnel plots and Egger’s tests. Finally, we also conducted a meta-regression analysis, using the metareg 
command in STATA,23 to assess the relationship between age and SMD for most proximal and probably blinded 
assessment of ADHD core symptoms. This analysis was conducted to establish whether the efficacy of cognitive 
training varied across age, a finding that could be of clinical significance.  
 
Results  
Fifteen trials (reported in 16 papers) met entry criteria (Supplemental Table S1). Studies not included in the 
meta-analysis are listed (with reasons for their exclusion) in the Supplemental Table S2. Figure 1 reports the trial 
selection flowchart. Table 1 gives information about retained trials. Results of all analyses are summarized in Table 2. 
Six trials were on working memory training; four on attention training; two combined attention and working memory 
training, two inhibition and working memory training and one provided a general executive function training covering 
working memory, inhibition and cognitive flexibility. All training schedules had an “adaptive” component, i.e., task 
difficulty was increased across sessions to track performance improvement. Eight trials had an active control condition. 
Six trials were implemented at home, five at school, two at either school or home, one in the clinic and one at the 
welfare service/children center, home or lab. Five trials had no/low medication levels. See Supplemental Figure 1 for 
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the graphic output for the risk of bias assessment. Risk of bias was generally low or unclear. No trials were scored “high 
risk” with regard to “random sequence generation”, “allocation concealment” and “incomplete outcome data”, and only 
three and four trials scored high for “blinding of participants/personnel” and “blinding of outcome assessment”, 
respectively (the rating of each studies is available upon request).  
ADHD symptoms: ADHD symptoms (total score or inattention or hyperactivity/impulsivity separately) were 
an outcome in up to 14 trials. Probably blinded measures were available in up to 11 trials (Table 2).  
When most proximal assessments were the outcome, there was a moderate but significant effect on total 
ADHD and inattention symptoms but no effect for hyperactivity/impulsivity (Figure 2; SMD and confidence interval 
data for all outcomes are presented in Table 2). In sensitivity analyses (Figure S2 and S3), considering only trials with 
an active control, the effects were no longer statistically significant for any ADHD core symptoms outcomes. There was 
no effect of working memory training when implemented on its own (Figure S2 and S3). In contrast, multi-process 
training approaches (i.e., approaches targeting more than one neuropsychological domain), gave a large effect size for 
total ADHD symptoms (Figure S2). Between-study heterogeneity of effect sizes was high and significant for total 
ADHD and inattention symptoms.  
When analyses were restricted to probably blinded measures (Figure 2), in general effect sizes were reduced 
with small and statistically marginal effects for all ADHD outcomes. In a sensitivity analysis (Figure S4), effect sizes 
dropped further to non-significant levels when only trials with an active control arm were included. There were 
insufficient studies (n< 5) for an analysis of probably blinded measures in multi-component training trials, as well as for 
a number of other sensitivity analyses.  
When analysis was restricted to no/low medication trials, effects on total ADHD symptoms were not 
significant for either most proximal or, when available, probably blinded assessments in any ADHD core symptom-
related outcome (Table 2).  
Neuropsychological outcomes: Eight trials included laboratory measures of verbal, and five visual working 
memory (Table 2). There was a large and significant effect of cognitive training on both components (Figure 3), which 
was maintained in sensitivity analyses considering trials with active controls only or working memory training trials 
only (Figure S5; sensitivity analyses were not performed for visual working memory because of an insufficient number 
of trials). The number of trials using multi-component training and no/low medication trials was insufficient to perform 
sensitivity analyses. There were no significant effects of training on laboratory tests of inhibition (six trials) or attention 
(seven trials) (Figure 3). Six trials included most proximal ratings of executive functioning using the BRIEF rating scale 
(Figure S6). These demonstrated a small-to-moderate, significant SMD. There was an insufficient number of trials with 
ratings of executive functioning to perform planned sensitivity analyses.  
 9 
Academic ability: Five trials included standardized measures of reading and five of arithmetic. There were no 
significant effects in either domain (Figure 3). There was an insufficient number of trials to perform planned sensitivity 
analyses. 
Publication bias: Funnel plots and results of Egger’s test are reported in Supplement 2. For both meta-analyses 
of ADHD symptoms scored by most proximal and probably blinded raters, the test failed to reach the p< 0.05 level, 
suggesting no significant publication bias. 
Meta-regression analysis: For most proximal or probably blinded assessments of ADHD core symptoms, there 
was no significant effect of age on SMD (Supplement 3).   
Sensitivity analysis excluding the study by Gray et al.22:  Main results considering most proximal assessment 
of ADHD core symptoms were substantially unchanged, as reported in Figure S7. As this study was not included in 
“probably blinded” analyses, no sensitivity analysis was conducted considering probably blinded assessment 
 
Discussion  
There are two perspectives on cognitive training in ADHD. From one, cognitive training is a front-line ADHD 
treatment – this is based on the hypothesis that because causal pathways to disorder are mediated by neuropsychological 
deficits, strengthening deficient neuropsychological functions should reduce ADHD symptoms and associated 
impairment. In the second, it is perceived as an adjunctive treatment which reduces impairment associated with 
neuropsychological deficits commonly seen in children with ADHD, independent of any effects on core ADHD 
symptoms itself. The current meta-analysis, including an additional 10 RCTs compared to the previous one by Sonuga-
Barke et al.,14 provided little support for cognitive training as a front-line ADHD treatment. There were statistically 
significant effects on ADHD symptoms when considering raters most proximal to treatment delivery, especially for 
symptoms of inattention. However, these effects were reduced substantially when analyses were limited to trials with an 
active control arm or where assessors were probably blind to treatment allocation. The evidence was somewhat stronger 
for the benefits of cognitive training as an adjunctive treatment aimed at reducing neuropsychological impairment. 
There were large and highly significant improvements on objective tests of both visual and verbal working memory – 
although there were no effects on inhibition or inattention. Further, the effects of cognitive training on working memory 
did not extend to the academic outcomes explored. 
 The substantial drop in SMDs between most proximal and probably blinded analyses for ADHD symptoms is 
similar to the pattern seen in previous meta-analyses of non-pharmacological treatments using the EAGG protocol (e.g., 
behavioral intervention;8 neurofeedback14). This is probably caused by the inflation of effect size estimates that 
inevitably occurs when one relies on raters who are both likely to be aware of treatment allocation and heavily invested 
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in the delivery and outcome of treatment. It is also possible that probably blinded and most proximal assessments 
differed in some way that reduced the sensitivity of the former to treatment-related change. However, the same 
measurement approaches were used for each (some parent, some teacher and some direct observation measures). 
Another possibility is that most proximal assessments accurately captured treatment effects established in the 
therapeutic setting but that these effects did not generalize to the settings in which probably blinded assessments were 
made. However, in a substantial minority of trials (Table 1), especially those with an active control arm, probably 
blinded measures were collected in the treatment setting, and the effects for these trials were no larger than those for 
trials where they were collected in a different setting.  
 The trials included in the meta-analysis employed a wide range of training approaches targeting different 
neuropsychological processes. There were a sufficient number of trials to look at two classes of intervention 
individually, which was not possible in the previous meta-analysis by Sonuga-Barke et al.14: training of working 
memory only and training focusing on multiple neuropsychological domains. The results for trials implementing 
working memory training only departed in a striking way from the most proximal/probably blinded pattern described 
above. Effects on ADHD were negligible even considering most proximal measures. This suggests that this form of 
training, which has been widely promoted for use with patients with ADHD (as discussed in9), has little or no efficacy 
for core ADHD symptoms. On the other hand, the SMD for most proximal assessment of ADHD symptoms was 
substantially larger for trials based on training targeting multiple domains than for all studies as a whole. Unfortunately, 
there was an insufficient number of trials (n=4) with probably blinded measures to corroborate these effects using 
independent sources. The superiority of these approaches may be due to the typically greater number of training 
sessions in multi- compared to single component approaches (in our analysis, on average nine weeks compared to six 
weeks, respectively). However, the finding opens up the interesting possibility that multi-component training models 
may be more successful for ADHD given the complex and heterogeneous nature of the condition. Since children with 
ADHD differ from one another in their neuropsychological profile and children may be affected by more than one 
deficit,24,25 multi-component training may be used to target a series of neuropsychological domains that may be more 
important than working memory alone in the pathophysiology of ADHD symptoms. The development and evaluation of 
multi-component training models should be a future priority.   
 The effects on neuropsychological outcomes were restricted to working memory, which were substantial, with 
no effects on inhibitory or attentional control. There were significant effects on parents’ ratings of executive function – 
but these could not be corroborated by independent blinded evidence. All six trials that included a working memory 
outcome were working memory training trials. Therefore, while these trials produced “near transfer” of training effects 
to untrained working memory measures – there was no evidence of “far transfer” to other neuropsychological processes. 
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Crucially, there was also no evidence that these effects generalised to important areas of everyday functioning, which 
themselves are influenced by working memory ability16 – such as reading and arithmetic. This finding may be relevant 
in clinical practice. Indeed, parents may currently favor cognitive training with the hope that they can improve academic 
performance. Our results show that this is not supported by empirical evidence. 
The success of working memory training in improving working memory performance draws into even sharper 
relief its failure to improve ADHD symptoms – suggesting a dissociation between neuropsychological functioning and 
disorder. There are four possible explanations for this. First, that working memory deficits do not in fact mediate 
ADHD pathophysiology.26 Second, that, although they do mediate the development of ADHD, they have become 
entrenched and not susceptible to the type of training implemented in trials conducted to date. Third, that training as 
currently implemented targets types of working memory not fundamental to the deficits in ADHD.9 Fourth, that training 
only produces peripheral, practice-like, effects on working memory, with no profound impact on the brain networks 
underpinning neuropsychological deficits responsible for ADHD. Whether or not working memory deficits are part of 
the causal mechanism underpinning ADHD, based on our results, strengthening working memory appears to be neither 
a necessary nor a sufficient condition for ADHD symptom reduction. In this regard, our findings suggest that choosing 
substrates which have emerged from experimental research as treatment targets may not necessarily translate into 
clinical benefits. This possible dissociation between candidate mechanisms of a disorder and clinical targets is 
important when adopting pathophysiology-based research approaches such as the Research Domain Criteria (RDoC).27 
From a clinical standpoint, developing techniques to extend transfer from the effects on core working memory 
processes to broader neuropsychological processes and important domains of impairment and/or clinical presentation is 
the most pressing challenge for the future. The reasons for the lack of effect on inhibitory and attentional control are 
hard to determine on the basis of the current analysis given the small number of trials that specifically targeted these 
domains. While we might predict that training targeting multiple deficit domains would show effects on these 
neuropsychological processes, there were insufficient trials with multi-component training and measures of inhibition 
and/or attention to test this. Approaches focusing on motivational or energetic processes may also be valuable (i.e., 
training to increase delay of gratification).28  
A number of limitations need to be taken into account when interpreting the current analysis. First, there was 
significant SMD heterogeneity for some analyses (most proximal total ADHD, symptoms of inattention, and visual 
working memory). This leaves open the possibility that cognitive training may be effective under specific circumstances 
in individual trials. Given the limited number of trials available we were unable to identify specific features of positive 
trials (apart from therapeutic content – working memory training). Second, only a minority of trials (n= 5) reported 
employing intention-to-treat analyses, a situation which may have inflated the effects for some outcomes as participants 
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who are harder to treat or who perceive the treatment as less beneficial may drop out of trials – however drop-out was 
relatively low in most trials. Third, despite the recent substantial increase in the number of available cognitive training 
trials, there was an insufficient number of trials to evaluate training approaches targeting specific neuropsychological 
constructs other than working memory training. Fourth, there were insufficient trials to run analyses for some important 
outcomes (e.g., functional impairment, IQ), as well as for sensitivity analyses or analyses restricted to probably blinded 
measures for a number of outcomes. Fifth, too few trials included long-term outcomes (see Table 1) to allow an 
evaluation of the extent to which effects on clinical symptoms grew over time or effects on neuropsychological 
processes persisted. Sixth, no trials were restricted to individuals with both ADHD and the specific neuropsychological 
deficit to be trained – as a consequence, effect sizes for both neuropsychological deficits and ADHD symptoms may 
have been truncated: in the former case because there would be little room for improvement where no deficit existed; in 
the later case because targeting a neuropsychological deficit that was not causing the condition would be unlikely to 
reduce symptoms of the core condition. Seventh, in the neuropsychological domains, diverse measures from different 
tasks (still tapping the same domain, though) were combined across studies to allow the calculation of pooled SMD 
estimates. Eight, it is important to understand whether initial symptom-related and neuropsychological treatment effects 
persist over time and generalize to other domains if they do. There were insufficient trials that examined long-term 
outcomes to address this issue. Finally, the categorization of studies as “probably blinded”, although carried out against 
pre-agreed and clear decision rules set out in the protocol, is limited by an inevitable degree of uncertainty due to 
limitations in the information reported in some trials. 
  In summary, the current meta-analysis found limited evidence for the clinical value of cognitive training for 
children with ADHD outside of the narrow confines of specific targeted neuropsychological processes (i.e., working 
memory training improved working memory function). Given evidence of neuropsychological heterogeneity in ADHD, 
future efforts should be directed at developing protocols to target a broader range of neuropsychological deficits. 
Furthermore, therapeutic innovation is required to enhance the “far transfer” of specific neuropsychological gains to 
everyday patterns of functional impairment through more ecologically valid training approaches.29 Future trials should 
more consistently include active control arms, a broader range of functional outcomes and long-term follow-up.   
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Table 1. Characteristics of studies included in the meta-analysis. Studies are listed in chronological order of publication. 
Trial           Design Training Sample Outcomes 
First 
author 
(year) A 
 
 
Type 
 
 
Control 
 
 
Length of 
training  
(days) 
and  
FU B 
 
 
Type 
 
 
Setting 
 N C 
 
T 
C 
Meds 
 
T (%) 
C (%) 
Age 
(months) 
ADHD 
M-
PROX  
ADHD 
P-BLIND  
Included 
neuropsychology- 
outcomes 
Academic 
functioning  
Klingberg 
(2005) 1 
2 groups 
 
NA-WMT 
35 
FU: 3 
months 
WMT 
RoboMemo 
(R) D 
school/ 
home 
26 
27 
   0 E 
0 
116 (mean) parent teacher 
digit span (verbal WM); 
span board (visual 
WM); stroop accuracy 
(inhibition) 
N/A 
Shalev 
(2007) 2 
2 groups 
computer 
games 
56 
No FU  
attention 
training  
clinic  
20 
16 
0 F 
0 F 
72-156 parent parent N/A In house tests  
Johnstone 
(2010) 3 
2 groups 
 
NA-WMT 
35 
No FU  
inhibitory and 
WMT  
home 
20 
20 
47 G 
78 G 
95-149 parent parent 
No go errors % 
(inhibition) 
N/A 
Rabiner H 
(2010) 4  
3 groups 
 
wait list 
 
98 
FU: 
within 1 y 
attention 
training 
Captain’s Log 
I 
school 
/home 
25 
25 H 
7 NS teacher N/A N/A 
Woodcock-
Johnson test 
Steiner  M 
(2011) 5 
3 groups 
 
wait list 
 
120 
No FU  
attention/ 
WMT 
Brain Train N 
school 
 
13 
15 
60 
 148.8 ± 
10.8 
(mean) 
parent teacher N/A N/A 
Tucha O 
(2011) 6  
3 groups 
visual 
perception 
training 
 28 
No FU  
attention 
training 
AixTent  
welfare 
service, 
home or 
lab 
16 
16 
   100 
   100 
124-138 N/A N/A 
vigilance omissions 
(inattention) 
N/A 
Johnstone P 
(2012) 7  
3 groups 
 
 
wait list 
 
35 
FU: 6 wks 
adaptive 
inhibitory 
training and 
WMT 
home 
22 
20 
90 95-145 parent NA 
counting span (verbal 
WM); Go NoGo, RT 
incongruent stimuli 
(inhibition); oddball 
task correct (attention) 
N/A 
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Gray 
(2012) 8 
2 groups 
adaptive 
math 
training 
Academy of 
Math 
35 
No FU  
adaptive 
WMT 
RoboMemo 
(R) D 
school 
32 
20 
98 144-204 teacher N/A 
digit span back (verbal 
WM); CANTAB spatial 
WM (visual WM); D2 
test total (attention) 
Wide-Range 
Achieve- 
ment  
Green 
(2012) 9 
2 groups 
 
NA-WMT 25  
No FU  
adaptive 
WMT 
RoboMemo 
(R) D 
home 
12 
14 
67 
14 
 84-168  parent parent 
WISC index (verbal 
WM) 
N/A 
Van der 
Oord 
(2012) 10 
2 groups 
 
 
wait list 
35 
FU: 9 wks  
adaptive EF 
training                 
(inhibition, 
WM, 
flexibility) 
home 
18 
22 
66 96-144 parent teacher N/A N/A 
Tamm 
(2013) 11 
2 groups 
 
 
wait list 56 
No FU 
Adaptive 
attention 
training 
Pay Attention! 
school 
45 
46 
65 
73 
84-180 parent clinician 
digit span (verbal WM); 
D-KEFS scaled score 
(inhibition), omissions 
(inhibition) 
N/A 
Chacko 
(2013) 12 
2 groups 
 
 
NA- WMT 
 
35 
No FU  
adaptive 
WMT 
RoboMemo 
(R) D 
home 
44 
41 
27 
32 
84-132 parent teacher 
AWMA listening 
(verbal WM); dot 
matrix (visual WM); 
CPT commissions 
(inhibition); omissions 
(attention) 
Wide-Range 
Achieve- 
ment 
Egeland Q 
(2013) 13 
2 groups 
 
 
TAU 
 
25  
FU: 8 
months 
adaptive 
WMT 
RoboMemo 
(R) D 
school 
33 
34 
68 120-144 teacher N/A 
 
Stroop interference 
score (inhibition; CPT 
focus (attention) 
Logos Test  
Hovik Q 
(2013) 14 
2 groups 
 
TAU 
 
25  
FU: 8 
months 
adaptive 
WMT 
RoboMemo 
(R) D 
  
school 
33 
34 
68 120-144 teacher N/A 
Digit span, (verbal 
WM); Leiter visual 
span (visual WM) 
N/A 
Steiner M 
(2014) 15 
3 groups     
(neurofeed-
back, 
cognitive 
 
 
TAU 
 
91 
No FU 
adaptive 
attention and 
WMT 
school 
34 
36 
41 
55 
100.8 ± 
14.8  
(mean) 
parent 
direct 
observa-
tion 
(BOSS) 
N/A N/A 
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training, 
control) 
Van 
Dongen-
Boomsma 
(2014) 16 
2 groups 
 
NA- WMT 
35 
No FU 
adaptive 
WMT 
(Cogmed 
Robo Memo) 
home, 
except 
for 1 
subject 
26 
21 
0 
0 
71.5-87.6 
investi- 
gator 
teacher 
digit span (verbal WM); 
Knox Cubes (visual 
WM); Stroop difference 
(inhibition); Sustained 
attention dots: SDRT 
(attention) 
N/A 
 
A Followed by study reference number, as in Supplemental Table S1 
B Long-term follow-up after first outcome measurement, when available  
C N is the number of individuals in the Treatment (T) and Control (C) conditions; D Cognitive Medical Systems AB, Stockholm, Sweden; E Two children stopped stimulants more 
than 1 year before the study; one discontinued stimulant medication 1 week before the study; the other participants were stimulant-naïve; F 4 participants in the treatment group 
and 3 the control group received psychostimulants throughout the duration of the study. None were medicated neither during the training sessions nor during the pre- and post-
testing sessions; G Participants were asked to refrain from taking ADHD medication in the 24 h prior to testing; H This study also included an arm on “Computer assisted 
instruction” not considered for the present meta-analysis; I Braintrain ®, http://www.braintrain.com/captainslogmentalgym; L 27 additional participants were allocated to 
Computer assisted instruction; M This trial also included an arm of neurofeedback (www.playattention.com); N http://www.braintrain.com/captains-log-personal-trainer/; O 
Results of this study are also reported in Lange KW, Tucha L, Hauser J, Lange KM, Stasik D, Tucha O. Attention training in Attention Deficit Hyperactivity Disorder. Aula 
Abierta 2012;40(3):55-60.; P This study also included a “software with attention monitoring” arm, not included in the present meta-analysis for consistency with interventions 
included in the other studies retained in the meta-analysis; Q These two papers refers to the same study and present analyses on different outcomes. 
 
Acronyms and abbreviations: AWMA: Automated Working Memory Assessment; C: Control Group; CANTAB: Cambridge Neuropsychological Test Automated Battery; EF: 
Executive Functions; NA-WMT: Non adaptive working memory training; T: Training Group; TAU: Treatment As Usual: WMT: Working Memory Training.  
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Table 2. Summary of results. Pooled standardized mean differences (SMD) between treatment and 
control arms for each outcomes. Significant effects are bolded.  
 
Outcome 
Trials 
included 
Measure 
Study 
n 
Effect Heterogeneity 
    SMD 95% CI p I2 p 
ADHD total 
all 
MPROX 14 0.37 0.09-0.66 0.01 71 <0.001 
PBLIND 11 0.20 0.01-0.40 0.04 30 0.16 
active 
control 
MPROX 7 0.16 -0.23-0.55 0.41 71 <0.001 
PBLIND 6 0.22 -0.09-0.53 0.17 42 0.13 
WMT MPROX 6 0.00 -0.31-0.31 1.00 56 0.05 
MPT MPROX 5 0.79 0.46-1.12 <0.001 36 0.18 
MED 
MPROX 5 0.19 -0.16-0.54 0.30 56 0.06 
PBLIND 5 0.11 -0.10-0.32 0.31 0 0.74 
inattention 
all 
MPROX 11 0.47 0.14-0.80 <0.01 76 <0.001 
PBLIND 9 0.32 -0.01-0.66 0.06 69 <0.001 
active 
control 
MPROX 5 0.30 -0.17-0.76 0.21 72 <0.001 
WMT MPROX 5 0.22 -0.18-0.62 0.28 66 <0.001 
MED MPROX 5 0.35 -0.09-0.79 0.29 71 0.02 
hyper/Imp 
all 
MPROX 9 0.14 -0.07-0.35 0.18 28 0.28 
PBLIND 8 0.18 -0.01-0.37 0.06 0 0.50 
active 
control 
MPROX 5 0.01 -0.25-0.22 0.91 0 0.60 
WMT MPROX 5 0.02 -0.24-0.21 0.89 0 0.68 
executive 
function rating 
all MPROX 6 0.35 0.08-0.61 0.01 22 0.22 
all objective 5 0.47 0.23-0.70 <0.01 69 <0.001 
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working 
memory 
(visual) 
active 
control 
objective insufficient trials (n=4) 
WMT objective 5 0.47 0.23-0.70 <0.01 69 <0.001 
working 
memory 
(verbal) 
all objective 8 0.52 0.24-0.80 <0.01 48 0.06 
active 
control 
objective 5 0.58 0.23-0.94 0.001 45 0.12 
WMT objective 6 0.57 0.29-0.82 <0.001 32 0.19 
Inhibition all objective 6 0.07 -0.15-0.28 0.53 2 0.4 
Attention all objective 7 0.14 -0.19-0.48 0.41 58 0.03 
Reading all 
Standardized 
tests 
5 0.09 -0.09-0.27 0.33 23 0.26 
Arithmetic all 
Standardized 
tests 
5 0.01 -0.13-0.11 0.84 0 0.44 
 
Note: Table reports only measures for which 5 or more trials were available “all” = all trials meeting inclusion 
criteria with available measure; “active controls” = all trials with an active control arm such as easy or non-
adaptive training; “WMT” = all trials using just Working Memory Training; “MPT” = Multiple Process 
Training; MED: trials in which < 30% of participants were treated with ADHD medication; MPROX: most 
proximal rater; PBLIND: probably blinded rater. Where only MPROX is reported there were insufficient trials 
with PBLIND measures.  
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FIGURES CAPTION 
 
Figure 1. Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) flow diagram 
of selection of studies (last search updated on May 18th, 2014). 
 
Footnote 
A 259: not ADHD; 342: not cognitive training; 7: not RCT; 47: reviews; 3: studies in adults; 1: study protocol 
B Reasons for exclusion of each study are reported in Supplemental Table S2 
C Egeland et al. (2013) and Hovik et al. (2013) refer to the same study 
 
 
Figure 2. Forest plots for meta-analysis of effects on ADHD core symptoms assessed by most proximal 
and probably blinded raters. 
  
Footnote 
References of included studies are listed in Supplemental Table S1.  
 
 
Figure 3. Forest plots for meta-analysis of effects on neuropsychological and academic outcomes. 
    
Footnote 
References of included studies are listed in Supplemental Table S1.  
 
